Jorge Emilio Ortega Calvo-rekin lankidetzan egindako argitalpenak (28)

2023

  1. Maternal Immune Activation Induces Cortical Catecholaminergic Hypofunction and Cognitive Impairments in Offspring

    Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 348-365

  2. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism

    Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350

  3. Psilozibinaren administrazio akutuaren eraginen ebaluazioa garun kortexean serotonina, noradrenalina eta dopamina mailak neurtuz: garun-mikrodialisiaren bidez burututako ikerlana esna dauden saguetan

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

2022

  1. Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response

    Biomedicine and Pharmacotherapy, Vol. 154

2021

  1. In Vivo Brain Microdialysis of Monoamines

    Neuromethods (Humana Press Inc.), pp. 489-512

  2. Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways

    Frontiers in Pharmacology, Vol. 12

2019

  1. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus

    Neuropharmacology, Vol. 158

  2. Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression

    Molecular Neurobiology, Vol. 56, Núm. 4, pp. 3038-3052

2018

  1. Serotonin 5-HT3 receptor antagonism potentiates the antidepressant activity of citalopram

    Neuropharmacology, Vol. 133, pp. 491-502

  2. Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions

    Neuropsychopharmacology, Vol. 43, Núm. 5, pp. 1041-1051

2017

  1. Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α2-adrenoceptors in rat brain

    Neuropharmacology, Vol. 114, pp. 114

2016

  1. Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study

    Psychopharmacology, Vol. 233, Núm. 23-24, pp. 3861-3867

  2. In vivo brain microdialysis of monoamines

    Neuromethods (Humana Press Inc.), pp. 415-434

2015

  1. Erratum: α2-adrenoceptor antagonists: Synthesis, pharmacological evaluation, and molecular modeling investigation of pyridinoguanidine, pyridino-2-aminoimidazoline and their derivatives (Journal of Medicinal Chemistry (2015) 58 (963-977) DOI: 10.1021/jm501635e)

    Journal of Medicinal Chemistry

  2. α2-adrenoceptor antagonists: Synthesis, pharmacological evaluation, and molecular modeling investigation of pyridinoguanidine, pyridino-2-aminoimidazoline and their derivatives

    Journal of Medicinal Chemistry, Vol. 58, Núm. 2, pp. 963-977

2014

  1. Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain

    Journal of Neuroinflammation, Vol. 11, Núm. 1

2013

  1. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain

    European Journal of Pharmacology, Vol. 709, Núm. 1-3, pp. 13-19

  2. Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.

    Translational psychiatry, Vol. 3

  3. Chronic pain leads to concomitant noradrenergic impairment and mood disorders

    Biological Psychiatry, Vol. 73, Núm. 1, pp. 54-62

  4. Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: A microdialysis study in rat brain

    Psychopharmacology, Vol. 229, Núm. 2, pp. 331-344